NASDAQ:CELZ Creative Medical Technology (CELZ) Stock Price, News & Analysis $0.84 -0.02 (-2.55%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$0.85 +0.01 (+0.89%) As of 10/9/2026 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsOwnershipSEC Filings About Creative Medical Technology Stock (NASDAQ:CELZ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CELZ alerts:Sign Up Key Stats Today's Range$0.82▼$0.8850-Day Range$0.65▼$1.4252-Week Range$0.62▼$6.25Volume147,681 shsAverage Volume1.24 million shsMarket Capitalization$5.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingHold Company Overview Creative Medical Technology Holdings, Inc. is a clinical-stage biotechnology company focused on developing regenerative medicine and cellular therapies. The company’s research uses adult stem cells and other cell-based approaches intended to address conditions with limited treatment options, including immune, neurological, metabolic and urological disorders. Its development programs have included CaverStem, an autologous bone marrow-derived cell therapy platform being investigated for erectile dysfunction, as well as ImmCelz and NeuroCelz programs designed to explore cell-based treatments for immune-related and neurological conditions. The company has also pursued therapies for diabetes and other chronic diseases. These programs are investigational and may require additional clinical testing and regulatory approval before they can be broadly marketed. Creative Medical Technology is based in the United States and has focused its activities primarily on developing and advancing its proprietary regenerative medicine platforms. The company’s shares trade on the Nasdaq Capital Market under the symbol CELZ. Publicly available information about its current leadership, commercial operations and geographic reach is limited, and the company’s principal activities remain centered on research, development and clinical-stage biotechnology programs.AI Generated. May Contain Errors. Read More Creative Medical Technology Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreCELZ MarketRank™: Creative Medical Technology scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.4 / 5Analyst RatingHold Consensus RatingCreative Medical Technology has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCreative Medical Technology has only been the subject of 2 research reports in the past 90 days.Read more about Creative Medical Technology's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Creative Medical Technology are expected to grow in the coming year, from ($1.18) to ($0.88) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Creative Medical Technology is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Creative Medical Technology is -0.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCreative Medical Technology has a P/B Ratio of 0.41. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Creative Medical Technology's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.52% of the float of Creative Medical Technology has been sold short.Short Interest Ratio / Days to CoverCreative Medical Technology has a short interest ratio ("days to cover") of 0.08, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Creative Medical Technology has recently increased by 95.57%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCreative Medical Technology does not currently pay a dividend.Dividend GrowthCreative Medical Technology does not have a long track record of dividend growth. News and Social Media1.5 / 5News Sentiment0.43 News SentimentCreative Medical Technology has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Creative Medical Technology this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for CELZ on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Creative Medical Technology insiders have not sold or bought any company stock.Percentage Held by Insiders1.00% of the stock of Creative Medical Technology is held by insiders.Percentage Held by Institutions1.42% of the stock of Creative Medical Technology is held by institutions.Read more about Creative Medical Technology's insider trading history. Receive CELZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CELZ Stock News HeadlinesCreative Medical Technology Expands Control of BioDefense SubsidiarySeptember 25, 2026 | tipranks.comCreative Medical Expands Ultrasome Intellectual Property PortfolioSeptember 18, 2026 | rttnews.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 11 at 1:00 AM | Stansberry Research (Ad)Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent FilingSeptember 17, 2026 | globenewswire.comCreative Medical Expands Authorized Shares and Warrant ExerciseAugust 31, 2026 | tipranks.comCreative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 ...August 20, 2026 | markets.businessinsider.comCreative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 PlanningAugust 20, 2026 | globenewswire.comCreative Medical receives US patent allowance for exosome-based type 1 diabetes immunotherapyAugust 6, 2026 | msn.comSee More Headlines CELZ Stock Analysis - Frequently Asked Questions How have CELZ shares performed this year? Creative Medical Technology's stock was trading at $1.96 at the beginning of 2026. Since then, CELZ shares have decreased by 57.2% and is now trading at $0.8385. How were Creative Medical Technology's earnings last quarter? Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) issued its quarterly earnings results on Friday, August, 7th. The company reported ($0.41) EPS for the quarter, missing analysts' consensus estimates of ($0.39) by $0.02. When did Creative Medical Technology's stock split? Creative Medical Technology's stock reverse split on Sunday, June 11th 2023.The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Creative Medical Technology? Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Creative Medical Technology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Creative Medical Technology investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), FuelCell Energy (FCEL), Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL) and ChargePoint (CHPT). Company Calendar Last Earnings8/07/2026Today10/11/2026Next Earnings (Estimated)11/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 3 weeks, CELZ's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:CELZ CIK1187953 Webwww.creativemedicaltechnology.com Phone(480) 399-2822FaxN/AEmployees4Year Founded2008Profitability EPS (Trailing Twelve Months)($2.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.99 million Net MarginsN/A Pretax Margin-201,300.02% Return on Equity-86.52% Return on Assets-81.96% Debt Debt-to-Equity RatioN/A Current Ratio12.90 Quick Ratio12.90 Sales & Book Value Annual Sales$10 thousand Price / Sales552.57 Cash FlowN/A Price / Cash FlowN/A Book Value$2.04 per share Price / Book0.41Miscellaneous Outstanding Shares6,590,000Free Float6,527,000Market Cap$5.53 million OptionableNot Optionable Beta2.06 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:CELZ) was last updated on 10/11/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
